Ann: Quarterly Update and Appendix 4C, page-114

RMD formed a joint venture with Verily (a Google subsidiary) nearly 2 years ago to develop a product like what RAP have developed and there has been no indicating that this has been completed, in fact, the last yearly financial for RMD indicate it was a $7M USD loss for that quarter.

"Citi considers ResMed an excellent business, although fairly valued. No break even date has been forecast for the Verily joint venture, which made a -US$7m loss in the quarter. The broker remains a little sceptical regarding the revenue model in this aspect of the business and looks forward to further clarity in time."

https://investors.resmed.com/invest...-Untreated-Sleep-Apnea-Sufferers/default.aspx

https://www.fnarena.com/index.php/2019/05/06/resmed-gains-share-in-core-sleep-market/